A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
暂无分享,去创建一个
M. Demoitié | E. Jongert | O. Ofori-Anyinam | P. Moris | N. Kumarasamy | S. Poongulali | Anne Bollaerts | L. Ayuk | F. Beulah | A. Bollaerts